Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.3 added; v3.4.2 removed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check31 days agoChange DetectedStudy status updated from Active, not recruiting to Completed, with enrollment changing from 576 to 598 and the completion date updated to 2026-02-02. Revision updated to v3.4.2.SummaryDifference0.9%

- Check38 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1; the previous version tag was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe update adds a Show glossary option and updates page metadata with new dates (2026-01-16 and 2026-01-20) and revision v3.4.0. Older dated entries and capitalization variations, as well as the No FEAR Act data text, were removed or adjusted.SummaryDifference0.2%

- Check59 days agoChange DetectedAdded a study site in Québec, Canada (G1V 4G5) and updated the page revision to v3.3.4. Removed the older Québec location and IPD-related entries.SummaryDifference0.9%

- Check87 days agoChange DetectedThe study Locations section was updated with new sites across multiple U.S. states and international locations (Canada and Chile) and the previous set of locations was removed.SummaryDifference2%

Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.